Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israël, Tel Aviv
Pelles Sharon
23 années d'expérience
La clinique est certifiée :
En Israël, la radiothérapie interne sélective (SIRT) coûte entre $24,500 et $33,500. Le tarif dépend de la complexité tumorale, de la dose de radiation et de l'établissement choisi. En France, les patients déboursent environ $40,000 pour ce traitement. Choisir Israël permet une économie d'environ 28%. Le coût inclut le radio-isotope, les actes de radiologie interventionnelle et le suivi oncologique initial.
Avis d'expert Bookimed : L'oncologie de précision au Sourasky Medical Center (Ichilov) offre une valeur exceptionnelle grâce à l'intégration technologique. Cet établissement accrédité JCI affiche un taux de succès de 90 % grâce à l'imagerie numérique et l'IA. La Dre Sharon Pelles et son équipe multidisciplinaire prodiguent des soins experts. Fréquenter ces centres assure l'accès à la recherche clinique et à des protocoles de sécurité rigoureux.
Pourquoi choisir Israël pour la thérapie SIRT ?
Accédez à des solutions avancées de thérapie SIRT dans des cliniques de confiance .
| Israël | Turquie | Espagne | |
| Thérapie SIRT | de $24,500 | de $24,000 | de $32,000 |
Bookimed ne facture pas de frais supplémentaires pour les prix des Thérapie SIRT. Les tarifs sont issus des listes de prix officielles des cliniques. Vous payez directement à la clinique lors de votre arrivée pour votre Thérapie SIRT.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans Thérapie SIRT et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de Thérapie SIRT.
Jour 1 : Arrivée
Jour 2-3 : Pré-opération
Jour 4 : Thérapie SIRT
Jours 5 à 7 : Post-opération
Semaine 1-2 : Rééducation
Semaine 3-4 : Poursuite de la rééducation
Veuillez noter qu'il s'agit d'une ligne directrice générale et que les expériences individuelles peuvent varier. Consultez toujours votre professionnel de la santé pour obtenir des conseils personnalisés.
Le Dr Pelles Sharon se spécialise dans la thérapie SIRT au centre médical Sourasky, apportant une vaste expertise dans les traitements avancés du cancer.
Le Prof. Merimsky dirige l'Unité d'oncologie des tissus mous et osseux au Centre médical Sourasky – l'un des meilleurs départements d'oncologie en Israël.
Dr. Amit Tirosh is the Head of the Neuroendocrine Tumors (NET) Service at Sheba Medical Center. He is an international authority on von Hippel–Lindau (VHL) disease and hereditary tumor syndromes. Dr. Tirosh contributed to global clinical guidelines for VHL management. He also leads the Endocrine Oncology Bioinformatics Lab at Sheba.
Dr. Almog Ben Yaacov is a senior surgical oncologist at Sheba Medical Center. He has performed over 200 HIPEC procedures for complex abdominal cancers. He focuses on treating gastric cancer, sarcoma, and colorectal malignancies. Dr. Ben Yaacov holds board certifications in both General Surgery and Surgical Oncology.
SIRT therapy, or Y90 radioembolization, is a minimally invasive treatment for inoperable liver tumors. In Israel, interventional radiologists inject radioactive Yttrium-90 microspheres into the liver artery. These beads lodge in tumor vessels, delivering targeted beta radiation while preserving healthy surrounding tissue.
Bookimed Expert Insight: Israeli oncology centers like Sourasky manage high patient volumes, seeing 40,000 cancer patients annually. This massive throughput allows specialists like Dr. Pelles Sharon to refine delivery protocols. High volumes often correlate with better outcomes in complex interventional radiology procedures.
Patient Consensus: Patients often refer to this treatment specifically as Y90 radioembolization. Many emphasize that this is internal radiation, which differs significantly from external beam therapies like SBRT.
SIRT treatment is safe and fully approved in Israel for treating inoperable liver tumors. The Israeli Ministry of Health, Joint Commission International (JCI), and FDA approve SIR-Spheres for clinical use. Leading oncology centers like Sourasky Medical Center (Ichilov) utilize this minimally invasive radioactive bead therapy safely.
Bookimed Expert Insight: While SIRT protocol for liver cancer is established, patients must distinguish it from SIRT-6 protein research. Israeli scientists are leaders in SIRT-6 age-reversing studies, but these are currently pre-clinical. When booking, specify selective internal radiation therapy to ensure you are reaching clinical oncology departments instead of research labs.
Patient Consensus: Patients are often advised to double-check if their specific case qualifies for SIRT versus other approved options like CAR-T therapy. High satisfaction is reported when coordinating with hospital international departments to verify the availability of certified radioactive isotopes.
SIRT therapy in Israel is a minimally invasive procedure delivering radioactive Yttrium-90 microspheres directly to liver tumors. Performed by specialists like Dr. Pelles Sharon at Sourasky Medical Center, it targets cancer cells with high-dose radiation while sparing healthy tissue and typically requires one week of recovery.
Bookimed Expert Insight: Israeli oncology centers like Sourasky manage massive volumes, seeing 40,000 cancer patients annually. This high frequency means teams are exceptionally fast at identifying the exact vascular map needed for bead delivery. Their expertise often reduces the time patients spend under specialized imaging, which minimizes overall radiation exposure during the mapping phase.
Patient Consensus: Many find the fatigue after SIRT more intense than expected, often lasting several weeks. While liver pain can linger for months, it is generally manageable with standard medication and rest.
SIRT therapy is available at major Israeli oncology centers including Sourasky Medical Center, Sheba Medical Center, and Assuta Medical Center. These JCI-accredited facilities provide radioembolization for liver cancer using multidisciplinary teams of interventional radiologists and nuclear medicine specialists in Tel Aviv and Ramat Gan.
Bookimed Expert Insight: While many patients search for SIRT, Israeli specialists like Dr. Beni Boursi at Sheba Medical Center often evaluate if NanoKnife or microwave ablation might be more effective. Choosing a hospital that offers all three technologies ensures your treatment is selected based on clinical need rather than equipment availability.
Patient Consensus: Patients are often advised to request radioembolization by name when contacting clinics. General sentiment highlights that major institutions have high radiotherapy capacity, often performing other advanced treatments like CAR-T alongside SIRT.